Deutsche Bank’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-148,374
| Closed | -$4.97M | – | 3836 |
|
|
2026
Q1 | $4.97M | Buy |
148,374
+6,392
| +5% | +$251K | ﹤0.01% | 1295 |
|
|
2025
Q4 | $6.57M | Buy |
141,982
+5,205
| +4% | +$285K | ﹤0.01% | 1208 |
|
|
2025
Q3 | $9.25M | Buy |
136,777
+9,444
| +7% | +$700K | ﹤0.01% | 1077 |
|
|
2025
Q2 | $10.7M | Buy |
127,333
+8,863
| +7% | +$663K | ﹤0.01% | 983 |
|
|
2025
Q1 | $8.46M | Sell |
118,470
-985
| -0.8% | -$48K | ﹤0.01% | 1053 |
|
|
2024
Q4 | $5.37M | Buy |
119,455
+36,971
| +45% | +$1.92M | ﹤0.01% | 1299 |
|
|
2024
Q3 | $4.16M | Buy |
82,484
+73,015
| +771% | +$3.5M | ﹤0.01% | 1356 |
|
|
2024
Q2 | $386K | Buy |
+9,469
| New | +$401K | ﹤0.01% | 2459 |
|
|
2021
Q2 | – | Sell |
-2,848
| Closed | -$54K | – | 4774 |
|
|
2021
Q1 | $54K | Sell |
2,848
-242
| -8% | -$7.8K | ﹤0.01% | 4218 |
|
|
2020
Q4 | $90K | Buy |
3,090
+836
| +37% | +$24.1K | ﹤0.01% | 3898 |
|
|
2020
Q3 | $85K | Buy |
2,254
+1,228
| +120% | +$35.9K | ﹤0.01% | 3627 |
|
|
2020
Q2 | $34K | Buy |
+1,026
| New | +$44.5K | ﹤0.01% | 3960 |
|
|
2019
Q4 | – | Sell |
-319
| Closed | -$7K | – | 5122 |
|
|
2019
Q3 | $7K | Sell |
319
-75
| -19% | -$2.39K | ﹤0.01% | 4600 |
|
|
2019
Q2 | $16K | Sell |
394
-1,899
| -83% | -$65.6K | ﹤0.01% | 4863 |
|
|
2019
Q1 | $70K | Buy |
+2,293
| New | +$60.9K | ﹤0.01% | 4446 |
|
|
2018
Q4 | – | Sell |
-3
| Closed | – | – | 5392 |
|
|
2018
Q3 | $0 | Sell |
3
-371
| -99% | -$13.5K | ﹤0.01% | 5539 |
|
|
2018
Q2 | $13K | Buy |
+374
| New | +$11K | ﹤0.01% | 5106 |
|
|
2017
Q4 | – | Sell |
-8,019
| Closed | -$311K | – | 5120 |
|
|
2017
Q3 | $311K | Buy |
8,019
+342
| +4% | +$13.5K | ﹤0.01% | 3646 |
|
|
2017
Q2 | $288K | Buy |
7,677
+8
| +0.1% | +$371 | ﹤0.01% | 3739 |
|
|
2017
Q1 | $408K | Buy |
7,669
+4,336
| +130% | +$256K | ﹤0.01% | 3199 |
|
|
2016
Q4 | $202K | Buy |
+3,333
| New | +$231K | ﹤0.01% | 3677 |
|
Deutsche Bank's SLNO Position: Q2 2026 in Review
Deutsche Bank sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 148,374 shares — an estimated $4.97M sold.
Deutsche Bank first reported a position in SLNO in Q4 2016 and held it in 21 quarters. The position peaked at $10.7M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Deutsche Bank reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Deutsche Bank sold 148,374 Soleno Therapeutics shares in Q2 2026, an estimated $4.97M.
- Deutsche Bank first reported a position in Soleno Therapeutics in Q4 2016 and held it in 21 quarters.
- Deutsche Bank's Soleno Therapeutics position peaked at $10.7M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.